Michael Mauboussin: Top 2% of Listed Companies account for 90% of Wealth creation.

In his latest article, Michael Mauboussin examines the demographics of public companies in the U.S., including how many are born, how long they live, why they die, and the returns they deliver to shareholders. This is highly relevant for investors as they approach valuation and portfolio construction. The skewness of outcomes is particularly striking.

Here are the key takeaways:

  • The number of public companies in the U.S. has declined significantly since peaking in 1996, with fewer new listings than delistings over that period. Academics estimate there is a “listing gap” of 5,800 to 12,200 companies between how many are currently listed versus how many should be listed.
  • About half of all public companies delist within 10 years of listing. The most common reasons for delisting are mergers and acquisitions (58% of delistings since 1976) and failure/cause (39%). Corporate longevity follows an exponential decay pattern.
  • A small percentage of companies account for most of the wealth creation in the stock market. From 1926-2022, just under 60% of companies destroyed $9.1 trillion in value while slightly over 40% created $64.2 trillion. The top 2% alone created over 90% of the net wealth.
  • These skewed outcomes have implications for valuation, suggesting investors should consider a range of possible end states rather than simple extrapolation. For portfolio construction, the results support either broad diversification to capture the skewness or concentrated portfolios that seek to own the wealth creators and avoid the destroyers.
  • The composition of the U.S. stock market has changed significantly, with mega-cap companies now representing a much larger share than in the past as the number of micro-caps has dwindled. This impacts key market characteristics investors should consider.

The skewness in corporate wealth creation suggests two potential investment approaches. The first is to seek broad diversification in an index fund. If the future is similar to the past, the outperformance of the wealth creators will more than make up for the underperformance of the losers. The second is to build a portfolio that seeks to avoid the wealth destroyers while owning the wealth creators.

Share the news

Disclaimer of liability

The above has been prepared by Børsgade ApS for information purposes and cannot be regarded as a solicitation or recommendation to buy or sell any security. Nor can the information etc. be regarded as recommendations or advice of a legal, accounting or tax nature. Børsgade cannot be held liable for losses caused by customers’/users’ actions – or lack thereof – based on the information in the above. We have made every effort to ensure that the information in the above is complete and accurate, but cannot guarantee this and accept no liability for errors or omissions.

Readers are advised that investing may involve a risk of loss that cannot be determined in advance, and that past performance and price development cannot be used as a reliable indicator of future performance and price development. For further information please contact info@borsgade.dk

You might also find this interesting:

Michael Mauboussin: Drawdowns Are The Unavoidable Cost of Long-Term Investing

Michael Mauboussin from Morgan Stanley Investment Management have published a comprehensive analysis examining stock market drawdowns and recovery patterns from 1985 to 2024. The research reveals that even the most successful investments experience severe price declines, with the median stock suffering an 85% drawdown that takes 2.5 years from peak to trough.

The study analyzed over 6,500 companies and found that more than half never recover to their previous highs. Michael’s work demonstrates that large drawdowns are an inevitable feature of equity investing, affecting individual stocks, mutual funds, and even portfolios with perfect foresight.

Thomas Gayner: My Current Take on Novo Nordisk

In his interview, Tom Gayner, CEO of Markel Group, reflects on investment principles shaped by Warren Buffett and Charlie Munger, and offers a detailed assessment of Novo Nordisk. Gayner praises Novo Nordisk for its business quality, global leadership in diabetes treatment, and strong growth trajectory. He credits the company’s disciplined management and innovation in pharmaceuticals as exemplary, aligning with his own standards of long-term value creation.

Michael Mauboussin: Put Expected Value In Your Valuation Toolkit

In this article, Michael Mauboussin explores how investors can generate excess returns by focusing on the gap between price and value, emphasizing the practicalities and psychology of expected value in investment decisions. He explains that while price is observable, value is inherently probabilistic, requiring careful estimation of possible payoffs and their probabilities.

The paper covers the challenges of modeling uncertainty, the importance of considering both probabilities and payoffs, the psychological hurdles investors face (like loss aversion), and best practices for applying these concepts across asset classes.

Bill Ackman: Success is Not A Straight Line Up

In the 2025 UBS Berkshire Hathaway Fireside Chat, Bill Ackman and Ryan Israel from Pershing Square Capital discuss investment philosophy, market volatility, the impact of tariffs and geopolitics, and lessons from Warren Buffett.

The conversation covers how to identify durable, high-quality businesses, the importance of long-term thinking, and the evolving landscape for activist investing. Ackman shares personal reflections on resilience, mentorship, and the role of free speech, while both speakers provide practical advice for young investors and fund managers.